Key result
Lower ventricular stiffness linked to ~30% greater adverse outcome risk per SD in Fontan patients.
Why the study?
End-diastolic pressure is influenced by loading conditions and extracardiac constraint and may not accurately reflect chamber stiffness, prompting investigation into ventricular chamber stiffness and its prognostic role in Fontan circulation.
Is lower ventricular chamber stiffness associated with adverse outcomes in patients with a Fontan circulation?
Cohort (n=814)
Is lower ventricular chamber stiffness associated with adverse outcomes in patients with a Fontan circulation?
Lower ventricular chamber stiffness, rather than progressive stiffening, is associated with adverse outcomes in patients with a Fontan circulation, identifying a high-risk eccentric remodeling phenotype.
Answers are grounded in this paper and cite their sources.
Signals high-risk eccentric remodeling in Fontan patients; hypothesis-generating and requires prospective validation before clinical adoption.
BACKGROUND: Rising end-diastolic pressure in patients with a Fontan circulation has led to the hypothesis that circulatory failure is driven by progressive ventricular stiffening. However, end-diastolic pressure is influenced by loading conditions and extracardiac constraint and may not accurately reflect chamber stiffness. We aimed to characterize ventricular chamber stiffness using the end-diastolic pressure-volume relationship and examine its clinical and prognostic significance in patients with a Fontan circulation. METHODS: In the FORCE registry (Fontan Outcomes Registry Using Clinical Examinations), chamber stiffness was quantified with the exponential coefficient β derived from single-beat end-diastolic pressure-volume relationship reconstruction using paired catheterization and cardiovascular magnetic resonance data. The β values were standardized as body surface area– and sex-based Z scores and related to clinical characteristics, ventricular remodeling, and a composite adverse outcome (death, transplantation listing, sustained atrial or ventricular arrhythmias, protein-losing enteropathy, or plastic bronchitis). RESULTS: Among 814 patients (median age, 14.7 years), median β was 0.034 mL −1 (0.025–0.046). Lower β Z score was associated with dominant right ventricle, eccentric remodeling with reduced ejection fraction, increased collateral flow and intracardiac recirculation, greater symptom burden, and higher arrhythmia prevalence, despite similar filling pressures. Over a median follow-up of 2.7 years (0.9–6.1 years), lower β Z score independently predicted adverse outcomes (adjusted hazard ratio, 1.30 per 1-SD decrease [95% CI 1.04–1.61]). A β Z score <−0.71, β<0.025 mL −1 , or body surface area–indexed end-diastolic volume >103 mL/m 2 showed similarly modest discrimination for adverse outcomes overall (area under the curve, 0.59), with greater discrimination in dominant right ventricles. CONCLUSIONS: Contrary to prevailing assumptions, lower rather than higher chamber stiffness was associated with adverse Fontan outcomes, identifying a high-compliance phenotype characterized by ventricular dilation and eccentric remodeling. These findings suggest that, in the contemporary FORCE cohort, Fontan failure might be more closely associated with this remodeling phenotype than with progressive stiffening.
No takes yet. Share an insight, caveat, or question.
Eynde et al. (2026) conducted a cohort in Fontan circulation (n=814). Lower ventricular chamber stiffness (lower β Z score) was evaluated on composite adverse outcome (death, transplantation listing, sustained atrial or ventricular arrhythmias, protein-losing enteropathy, or plastic bronchitis) (HR 1.30, 95% CI 1.04-1.61). Lower ventricular chamber stiffness independently predicted adverse outcomes in patients with a Fontan circulation.
Synapse has enriched 10 related papers. Consider them for comparative context: